Work

Hormonal Treatment for Breast Carcinoma

Year: 2025

Type: article

Abstract: Breast carcinoma (BCa) is the primary cause of death in women of these common types is estrogen-positive BCa. Endocrine treatment is mainly focused on estrogen receptor-positive BCa. The concept of ER-positive BCa is a quickly evolving area. As a result of several clinical trials conducted over the past 20 years Survival rates have been increased for patients with hormone-positive cancer at all stages. As a result, the primary care physician will be more actively involved in the ongoing monitoring, treatment, and control of issues linked to antihormonal therapy. The purpose of the current research was to highlight recent developments in the area of antihormonal therapy while also providing a succinct summary of issues about fundamental care.

Source: Journal of Datta Meghe Institute of Medical Sciences University

DOI: 10.4103/jdmimsu.jdmimsu_158_23

Authors: Kanchan H. Morey, Janhavi M. Sabnis, Pranil S. Shinde, Rushikesh Shukla, Shailja Singh, Nikhil Deep Kolanu, Ved Kaulgud

Institutions: Datta Meghe Institute of Higher Education and Research, China Medical University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4409143483

FWCI:

Cites: 23

Cited by:

Related to: 10